Who are Gain Therapeutics, Inc.'s main suppliers?

Gain Therapeutics, Inc. (GANX) key suppliers include: MINORYX-THERAPEUTICS-SL, Alector, Inc.. View the full supplier network at chainsifter.com/chain/GANX.

Who are Gain Therapeutics, Inc.'s major customers?

Gain Therapeutics, Inc. (GANX) key customers include: CAPITAL-RESOURCES, Carpenter Technology Corporation. View the full customer network at chainsifter.com/chain/GANX.

What sector is Gain Therapeutics, Inc. in?

Gain Therapeutics, Inc. (GANX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Gain Therapeutics, Inc. (GANX): 6 Verified Supply Chain Relationships

2Suppliers

2Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Gain Therapeutics, Inc. (GANX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships

2Distinct source URLs

4High confidence

0.797Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Gain Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
MINORYX-THERAPEUTICS-SL	MINORYX-THERAPEUTICS-SL	92%	In December 2017, the Company entered into an exclusive worldwide, royalty-bearing, assignable, transferable license agreement with Minoryx to use and exploit Minoryx’s intellectual property
ALEC	Alector, Inc.	72%	Reciprocal relationship from ALEC graph: t on our business and could potentially cause us to cease operations. We may not be successful in our efforts to further develop our current product candidate…

Gain Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	, as compared to $40 thousand for the three months ended March 31, 2025. The increase was mainly attributable to higher interest income from a higher balance in our money market fund over the compara…
CRS	Carpenter Technology Corporation	62%	Reciprocal relationship from CRS graph: Reciprocal relationship from GANX graph: , as compared to $40 thousand for the three months ended March 31, 2025. The increase was mainly attributable to highe…

Gain Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
GANX-DEBT	Debt stack $343,686	90%	Market cache reports total debt of $343,686.
GANX-DEBT-9714	Warrants outstanding: 200000	90%	xbrl warrant detail from xbrl 2025-12-31.

Gain Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Gain Therapeutics, Inc..

Gain Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
GANX-OWNER-MARSHALL-WACE-LLP	MARSHALL WACE, LLP	90%	13F overlay lists MARSHALL WACE, LLP as top holder; 43 tracked holders.

Gain Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
CRS	Carpenter Technology Corporation	100.00	1	['customer']
LLY	Eli Lilly and Company	100.00	2
VYGR	Voyager Therapeutics, Inc.	100.00	2
ALEC	Alector, Inc.	100.00	1	['supplier']
HTGC	Hercules Capital, Inc.	100.00	2
CLS	Celestica Inc.	50.00	2
CPS	Cooper-Standard Holdings Inc.	50.00	2
BLSH	Bullish	50.00	2
GDYN	Grid Dynamics Holdings, Inc.	50.00	2
CART	Maplebear Inc.	50.00	2
BRCC	BRC Inc.	50.00	2
ACVA	ACV Auctions Inc.	50.00	2
HXHX	Haoxin Holdings Limited	50.00	2
BHB	Bar Harbor Bankshares	50.00	2
BCO	The Brink's Company	50.00	2
CORZ	Core Scientific, Inc.	50.00	2
BRBI	BRBI BR Partners S.A.	50.00	2
DY	Dycom Industries, Inc.	50.00	2
FRSH	Freshworks Inc.	50.00	2
FIHL	Pelagos Insurance Capital Limited	50.00	2

Gain Therapeutics, Inc. Supply Chain